Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Toiron

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Oncotarget|February 28, 2016
MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 studyEmeline Tabouret, François Bertucci, Jean-Yves Pierga, et al.
EMBO Reports|March 28, 2025
Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6Emanuela Senatore, Rosario Avolio, Laura Rinaldi, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Oncotarget|February 28, 2016
MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 studyEmeline Tabouret, François Bertucci, Jean-Yves Pierga, et al.
EMBO Reports|March 28, 2025
Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6Emanuela Senatore, Rosario Avolio, Laura Rinaldi, et al.
Pageof 2